Natixis Buys 146,647 Shares of Corteva, Inc. (NYSE:CTVA)

Natixis increased its stake in shares of Corteva, Inc. (NYSE:CTVA) by 435.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 180,306 shares of the company’s stock after acquiring an additional 146,647 shares during the quarter. Natixis’ holdings in Corteva were worth $10,398,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of CTVA. CVA Family Office LLC bought a new position in Corteva during the fourth quarter worth about $25,000. Redmont Wealth Advisors LLC purchased a new position in shares of Corteva in the first quarter worth $25,000. Acadian Asset Management LLC bought a new stake in Corteva in the first quarter valued at $25,000. BKM Wealth Management LLC bought a new stake in Corteva in the fourth quarter valued at $27,000. Finally, Rise Advisors LLC boosted its holdings in shares of Corteva by 2,522.2% during the 1st quarter. Rise Advisors LLC now owns 472 shares of the company’s stock valued at $27,000 after buying an additional 454 shares in the last quarter. 81.54% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on CTVA shares. Barclays boosted their target price on Corteva from $55.00 to $58.00 and gave the stock an “equal weight” rating in a research report on Wednesday, April 10th. BMO Capital Markets upped their price target on Corteva from $64.00 to $67.00 and gave the stock an “outperform” rating in a research note on Friday, May 3rd. OTR Global restated a “negative” rating on shares of Corteva in a research note on Friday, June 7th. Mizuho cut their target price on shares of Corteva from $61.00 to $60.00 and set a “buy” rating for the company in a report on Tuesday, June 18th. Finally, Canaccord Genuity Group raised their target price on shares of Corteva from $60.00 to $65.00 and gave the company a “buy” rating in a report on Friday, May 3rd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $63.00.

Insider Buying and Selling at Corteva

In other Corteva news, insider Samuel R. Eathington sold 31,686 shares of Corteva stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $57.64, for a total value of $1,826,381.04. Following the transaction, the insider now owns 53,854 shares in the company, valued at $3,104,144.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Samuel R. Eathington sold 31,686 shares of the business’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $57.64, for a total transaction of $1,826,381.04. Following the sale, the insider now owns 53,854 shares in the company, valued at $3,104,144.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Brian Titus sold 12,134 shares of the business’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $56.65, for a total value of $687,391.10. Following the sale, the insider now owns 13,495 shares in the company, valued at approximately $764,491.75. The disclosure for this sale can be found here. Insiders have sold 83,556 shares of company stock worth $4,795,016 over the last quarter. Insiders own 0.14% of the company’s stock.

Corteva Stock Up 2.7 %

Shares of CTVA stock traded up $1.47 on Thursday, hitting $55.29. The stock had a trading volume of 2,796,530 shares, compared to its average volume of 3,433,574. The company has a quick ratio of 0.97, a current ratio of 1.51 and a debt-to-equity ratio of 0.10. The business has a 50 day moving average price of $53.71 and a 200 day moving average price of $53.51. The company has a market cap of $38.54 billion, a PE ratio of 70.22, a P/E/G ratio of 1.47 and a beta of 0.77. Corteva, Inc. has a one year low of $43.22 and a one year high of $58.76.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.89 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.10. The firm had revenue of $4.49 billion during the quarter, compared to the consensus estimate of $4.65 billion. Corteva had a return on equity of 6.68% and a net margin of 3.32%. The firm’s quarterly revenue was down 8.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.16 earnings per share. Research analysts anticipate that Corteva, Inc. will post 2.78 earnings per share for the current fiscal year.

Corteva Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Shareholders of record on Tuesday, June 4th were paid a $0.16 dividend. The ex-dividend date of this dividend was Tuesday, June 4th. This represents a $0.64 annualized dividend and a yield of 1.16%. Corteva’s dividend payout ratio (DPR) is presently 81.01%.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.